Franchini, Genoveffa
- Division of Basic Sciences - Nci (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #444
- Sustained Excellence
- Top 5% Funded
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$7M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#444
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Franchini, Genoveffa as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC012025-03ZIAContact PIPhase I HIV vaccine trial with DNAALVAC-HIV gp120 delta V1 vaccines$4.1Maward amount
- 1ZIABC011126-16ZIAContact PIDevelopment of rationally designed HIV vaccines$2.7Maward amount
- 1ZIABC005645-34ZIAContact PIRole of the HTLV-1A and HTLV1-C inflammatory profile in disease$166.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Franchini, Genoveffa as a PI.
FY2023 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardDivision of Basic Sciences - Nci
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #674
- 2007Entered Top 25% NationallyRanked #674
- 2007Entered Top 10% NationallyRanked #674
- 2007Entered Top 5% NationallyRanked #674
- 2008$5M Cumulative Funding
- 2009$10M Cumulative Funding
- 2012$25M Cumulative Funding
- 2018$50M Cumulative Funding
- 2021Entered Top 1% NationallyRanked #135